Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

OraSure Technologies, Inc. - Common Stock (NQ: OSUR )

3.060 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Feb 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 16,820
Open 3.060
Bid (Size) 2.700 (10)
Ask (Size) 2.960 (1)
Prev. Close 3.060
Today's Range 3.060 - 3.060
52wk Range 2.685 - 8.040
Shares Outstanding 73,262,370
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
What's going on in today's session
Wondering how the US markets performed one hour before the close of the markets on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill
Here are the top movers in Wednesday's session.
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill

Performance

YTD
-13.56%
-13.56%
1 Month
-25.55%
-25.55%
3 Month
-20.31%
-20.31%
6 Month
-29.66%
-29.66%
1 Year
-56.47%
-56.47%

More News

Read More
Traders are paying attention to the gapping stocks in Wednesday's session.
Via Chartmill
Earnings Scheduled For February 25, 2025
Via Benzinga
OraSure Reports Fourth Quarter 2024 Financial Results
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure to Announce Fourth Quarter 2024 Financial Results and Host Earnings Call on February 25th
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure to Present at the J.P Morgan Healthcare Conference
From OraSure Technologies, Inc.
Via GlobeNewswire
CORRECTION - OraQuick® HIV Self-Test Now Approved for Use in Adolescents
From OraSure Technologies, Inc.
Via GlobeNewswire
OraQuick® HIV Self-Test Now Approved for Use in Adolescents
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure Technologies Acquires Sherlock Biosciences
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure Receives Federal Funding for Development of Marburg Virus Rapid Antigen Test
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure to Participate in Upcoming Investor Conference
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure Reports Q3 ’24 Revenue of $39.9 Million
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure to Announce Third Quarter 2024 Financial Results and Host Earnings Call on November 6th
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure Technologies Elects Jack Kenny to the Board of Directors
From OraSure Technologies, Inc.
Via GlobeNewswire
OSUR Stock Earnings: OraSure Technologies Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
OraSure Reports Q2 ’24 Revenue of $54.3 Million
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure to Announce Second Quarter 2024 Financial Results and Host Earnings Call on August 6th
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure Technologies Supports National HIV Testing Day
From OraSure Technologies, Inc.
Via GlobeNewswire
CrowdStrike, KKR, GoDaddy To Join S&P 500 In Quarterly Rebalance; Stocks Jump
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
OSUR Stock Earnings: OraSure Technologies Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
OraSure Reports Q1 ’24 Revenue of $54.1 Million
From OraSure Technologies, Inc.
Via GlobeNewswire
Intelligent Bio Solutions Screening Technologies Poised to Disrupt The Healthcare Sector: INBS, LH, ABT, DGX
Via AB Newswire
Intelligent Bio Solutions’ Fingerprint Drug Screening Technology Poised For Massive Growth
Via Talk Markets
OraSure to Announce First Quarter 2024 Financial Results and Host Earnings Call on May 8th
From OraSure Technologies, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.